CVS Caremark Takes $290M Overbilling Judgment To 3rd Circ.
By P.J. D'Annunzio · September 16, 2025, 4:46 PM EDT
CVS's pharmacy benefits manager will appeal a judgment against the company that was recently increased from $95 million to $290 million in a suit alleging it overbilled Medicare Part D-sponsored drugs,...
To view the full article, register now.